Borealis Biosciences
PrivateLast Round
Series A
Extension
Dec 19, 2024
Total Funding Raised
$210M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Borealis Biosciences is a biotechnology company that develops next-generation xRNA-based medicines for kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Borealis Biosciences Comparables
Compare Borealis Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Judo Bio | 84% | |
| Purespring Therapeutics | 83% | |
| Zeal Therapeutics, Inc. | 82% |
Borealis Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 19, 2024 | ||||
| Series A | Aug 22, 2024 |
Key People
Founding team and executive leadership
Borealis Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A, Series A Extension |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 35% to 2.2K.
- Aug 22, 2024
$180M round led by Novartis and Westlake Village BioPartners.
Borealis Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Borealis Biosciences's valuation, stock price, and market status.
Is Borealis Biosciences a public or private company?
Borealis Biosciences is a private company.
What is the current stock price of Borealis Biosciences?
Borealis Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Borealis Biosciences worth (valuation)?
Valuation information for Borealis Biosciences is not publicly available.
Can I buy Borealis Biosciences stock?
Borealis Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Borealis Biosciences's last funding round?
Borealis Biosciences's most recent funding round was Series A Extension on December 19, 2024.
Who are the main investors in Borealis Biosciences?
Key investors in Borealis Biosciences include Westlake Village Biopartners.
Will Borealis Biosciences IPO soon?
No public IPO plans have been announced for Borealis Biosciences.
How can I track Borealis Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Borealis Biosciences's secondary market activity and sign up for updates.